Taken together, our findings demonstrate for the first time that the expression and subcellular localization of phosphorylated EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner, suggesting a correlation with lymph node metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.